Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Global, Regional, and National Survey on Burden and Quality of Care Index of Multiple Sclerosis: Global Burden of Disease Systematic Analysis 1990-2019 Publisher Pubmed



Maroufi SF1 ; Shobeiri P1 ; Mohammadi E1, 2 ; Azadnajafabad S1 ; Malekpour MR1 ; Ghasemi E1 ; Rashidi MM1 ; Saeedi Moghaddam S1, 3 ; Rezaei N1 ; Sharifnejad Tehrani Y1 ; Mohammadi Fateh S1 ; Ahmadi N1 ; Farzi Y1 ; Rezaei N1 Show All Authors
Authors
  1. Maroufi SF1
  2. Shobeiri P1
  3. Mohammadi E1, 2
  4. Azadnajafabad S1
  5. Malekpour MR1
  6. Ghasemi E1
  7. Rashidi MM1
  8. Saeedi Moghaddam S1, 3
  9. Rezaei N1
  10. Sharifnejad Tehrani Y1
  11. Mohammadi Fateh S1
  12. Ahmadi N1
  13. Farzi Y1
  14. Rezaei N1
  15. Larijani B4
Show Affiliations
Authors Affiliations
  1. 1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Neurological Surgery, University of Oklahoma Health Sciences Center, Oklahoma, OK, United States
  3. 3. Kiel Institute for the World Economy, Kiel, Germany
  4. 4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Neuroepidemiology Published:2023


Abstract

Background: Multiple sclerosis (MS) is a common neurologic autoimmune disorder. We have used a newly introduced measure, Quality of Care Index (QCI), which is associated with the efficacy of care given to patients suffering from MS. Objectives: The aims of the study were to report and compare the quality of care given to MS patients in different regions and country. Methods: Primary measures were retrieved from Global Burden of Disease (GBD) from 1990 to 2019. Secondary measures (mortality-to-incidence ratio, DALY-to-prevalence ratio, prevalence-to-incidence ratio, and YLL-to-YLD ratio) were combined using principal component analysis, to form an essential component (QCI) (0-100 index with higher values representing better condition). Results: In 2019, there were 59,345 (95% UI: 51,818-66,943) new MS incident cases globally. Global QCI of 88.4 was calculated for 2019. At national level, Qatar had the highest quality of care (100) followed by Kuwait (98.5) and Greenland (98.1). The lowest QCI was observed in Kiribati (13.5), Nauru (31.5), and Seychelles (36.3), respectively. Most countries have reached gender equity during the 30 years. Also, QCI was lowest in ages from 55 to 80 in global scale. Conclusion: MS QCI is better among those countries of higher socioeconomic status, possibly due to better healthcare access and early detection in these regions. Countries could benefit from adopting the introduced QCI to evaluate the quality of care given to MS patients at national and global level. © 2023 The Author(s).Published by S. Karger AG, Basel.
Related Docs
View other Related Docs
1. Global, Regional, and National Burden and Quality of Care Index of Liver Cirrhosis by Cause From Global Burden of Disease 1990–2019, Journal of Gastroenterology and Hepatology (Australia) (2023)
2. Quality of Care of Peptic Ulcer Disease Worldwide: A Systematic Analysis for the Global Burden of Disease Study 1990-2019, PLoS ONE (2022)
3. Burden and Quality of Care Index of Chronic Kidney Disease: Global Burden of Disease Analysis for 1990-2019, Nephrology Dialysis Transplantation (2024)
4. The Global, Regional, and National Burden and Quality of Care Index (Qci) of Colorectal Cancer; a Global Burden of Disease Systematic Analysis 1990–2019, PLoS ONE (2022)
5. Global and Regional Quality of Care Index for Prostate Cancer: An Analysis From the Global Burden of Disease Study 1990–2019, Archives of Public Health (2023)
6. Global, Regional, and National Survey on Burden and Quality of Care Index (Qci) of Nasopharyngeal Cancer: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Oral Oncology Reports (2024)
7. Global and Regional Quality of Care Index (Qci) by Gender and Age in Oesophageal Cancer: A Systematic Analysis of the Global Burden of Disease Study 1990-2019, PLoS ONE (2023)
8. Prevalence and Incidence of Multiple Sclerosis in Ardabil, Northwest of Iran, Multiple Sclerosis and Related Disorders (2021)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (24)
Farshad Farzadfar (23)
Other Related Docs
9. A Global, Regional, and National Survey on Burden and Quality of Care Index (Qci) of Bladder Cancer: The Global Burden of Disease Study 1990–2019, PLoS ONE (2022)
10. Epidemiology of Brain and Other Central Nervous System Cancers in the North Africa and Middle East Region: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, World Neurosurgery (2023)
11. Global, Regional, and National Burden and Quality of Care Index (Qci) of Bipolar Disorder: A Systematic Analysis of the Global Burden of Disease Study 1990 to 2019, International Journal of Social Psychiatry (2023)
12. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
13. Neuroscience20 (Brain20, Spine20, and Mental20) Health Initiative: A Global Consortium Addressing the Human and Economic Burden of Brain, Spine, and Mental Disorders Through Neurotech Innovations and Policies, Journal of Alzheimer's Disease (2021)
14. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the Gbd Study 2019, Journal of the American Heart Association (2024)
15. Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause From Global Burden of Disease 1990-2019, Hepatology Communications (2022)
16. Increasing Prevalence of Familial Recurrence of Multiple Sclerosis in Iran: A Population Based Study of Tehran Registry 1999-2015, BMC Neurology (2018)
17. The Quality of Care Index for Low Back Pain: A Systematic Analysis of the Global Burden of Disease Study 1990–2017, Archives of Public Health (2023)
18. National and Subnational Burden of Brain and Central Nervous System Cancers in Iran, 1990–2019: Results From the Global Burden of Disease Study 2019, Cancer Medicine (2023)
19. Global, Regional, and National Burden and Quality of Care Index (Qci) of Lip and Oral Cavity Cancer: A Systematic Analysis of the Global Burden of Disease Study 1990–2017, BMC Oral Health (2021)
20. Estimation the Medical Cost of Multiple Sclerosis in Iran; 2019–2020, BMC Health Services Research (2022)
21. Neonate, Infant, and Child Mortality by Cause in Provinces of Iran: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
22. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
23. Clinical Features of Late-Onset Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
24. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
25. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2021)
26. Shedding Light on Biological Sex Differences and Microbiota–Gut–Brain Axis: A Comprehensive Review of Its Roles in Neuropsychiatric Disorders, Biology of Sex Differences (2022)
27. Epidemiology of Familial Multiple Sclerosis: A Population-Based Study in Tehran During 1999–2018, Multiple Sclerosis and Related Disorders (2020)
28. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
29. Diabetes Mortality and Trends Before 25 Years of Age: An Analysis of the Global Burden of Disease Study 2019, The Lancet Diabetes and Endocrinology (2022)
30. Expansion of the Quality of Care Index on Breast Cancer and Its Risk Factors Using the Global Burden of Disease Study 2019, Cancer Medicine (2023)
31. Evidence of an Increased Prevalence of Multiple Sclerosis: A Population-Based Study of Tehran Registry During 1999-2018, BMC Neurology (2020)
32. Global, Regional, and National Quality of Care of Ischaemic Heart Disease From 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study 2017, European Journal of Preventive Cardiology (2022)
33. Regional and National Burden of Leukemia and Its Attributable Burden to Risk Factors in 21 Countries and Territories of North Africa and Middle East, 1990–2019: Results From the Gbd Study 2019, Journal of Cancer Research and Clinical Oncology (2023)
34. National and Provincial Prevalence of Cigarette Smoking in Iran; a Systematic Analysis of 12 Years of Steps Experience, Archives of Iranian Medicine (2023)
35. The Cost-Utility Analysis of Adding Ocrelizumab to the Treatment Plan for Primary Progressive Multiple Sclerosis in Iran, Expert Review of Pharmacoeconomics and Outcomes Research (2025)
36. Burden of Disease Scenarios for 204 Countries and Territories, 2022–2050: A Forecasting Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
37. National and Subnational Burden of Female and Male Breast Cancer and Risk Factors in Iran From 1990 to 2019: Results From the Global Burden of Disease Study 2019, Breast Cancer Research (2023)
38. Impact of an Existential-Spiritual Intervention Compared With a Cognitive-Behavioral Therapy on Quality of Life and Meaning in Life Among Women With Multiple Sclerosis, Iranian Journal of Psychiatry (2020)
39. Impact of Alcohol Consumption on Multiple Sclerosis Using Model-Based Standardization and Misclassification Adjustment Via Probabilistic Bias Analysis, Archives of Iranian Medicine (2023)
40. Level and Trend of Total Plasma Cholesterol in National and Subnational of Iran: A Systematic Review and Age-Spatio-Temporal Analysis From 1990 to 2016, Journal of Diabetes and Metabolic Disorders (2022)
41. Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report, JGH Open (2023)
42. Cost-Utility Analysis of Multiple Sclerosis Rehabilitation in Iran, Expert Review of Pharmacoeconomics and Outcomes Research (2023)
43. Socioeconomic Determinants of Global Distribution of Multiple Sclerosis: An Ecological Investigation Based on Global Burden of Disease Data, BMC Neurology (2021)
44. Age and Sex Adjusted Prevalence and Annual Incidence of Multiple Sclerosis in East-Azerbaijan, Iran, Multiple Sclerosis and Related Disorders (2021)
45. Global, Regional, and National Quality of Care Index (Qci) of Gastric Cancer: A Systematic Analysis for the Global Burden of Disease Study 1990-2017, Journal of Gastrointestinal Cancer (2024)
46. Global, Regional, and National Burden and Quality of Care Index of Endocarditis: The Global Burden of Disease Study 1990–2019, European Journal of Preventive Cardiology (2022)
47. History of Multiple Sclerosis in Iran, Archives of Iranian Medicine (2020)
48. The Higher Prevalence of Multiple Sclerosis Among Iranian Georgians; New Clues to the Role of Genetic Factors, Revue Neurologique (2020)
49. Prevalence of Multiple Sclerosis and Its Clinical and Demographic Characteristics in Kurdish Populations in Western Iran (2020), Multiple Sclerosis and Related Disorders (2022)
50. Global, Regional, and National Burden of Upper Respiratory Infections and Otitis Media, 1990–2021: A Systematic Analysis From the Global Burden of Disease Study 2021, The Lancet Infectious Diseases (2025)